Cite
Findlay EG, Currie AJ, Zhang A, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8(8):1608106doi: 10.1080/2162402X.2019.1608106.
Findlay, E. G., Currie, A. J., Zhang, A., Ovciarikova, J., Young, L., Stevens, H., McHugh, B. J., Canel, M., Gray, M., Milling, S. W. F., Campbell, J. D. M., Savill, J., Serrels, A., & Davidson, D. J. (2019). Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology, 8(8), 1608106. https://doi.org/10.1080/2162402X.2019.1608106
Findlay, Emily Gwyer, et al. "Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy." Oncoimmunology vol. 8,8 (2019): 1608106. doi: https://doi.org/10.1080/2162402X.2019.1608106
Findlay EG, Currie AJ, Zhang A, Ovciarikova J, Young L, Stevens H, McHugh BJ, Canel M, Gray M, Milling SWF, Campbell JDM, Savill J, Serrels A, Davidson DJ. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019 May 01;8(8):1608106. doi: 10.1080/2162402X.2019.1608106. eCollection 2019. PMID: 31413918; PMCID: PMC6682359.
Copy
Download .nbib
